144 related articles for article (PubMed ID: 12903403)
1. [Expression of epidermal growth factor receptor in gestational trophoblastic tumours].
Xiang Y; Li Z; Cui Q; Yang X; Song H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):555-7. PubMed ID: 12903403
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
4. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
5. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
Fülöp V; Végh G; Doszpod J
Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
[TBL] [Abstract][Full Text] [Related]
6. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
Abdou A; Kandil M; El-Wahed MA; Shabaan M; El-Sharkawy M
Fetal Pediatr Pathol; 2013 Dec; 32(6):395-411. PubMed ID: 23438793
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor in gestational trophoblastic diseases.
Balaram P; John M; Rajalekshmy TN; Nair B; Schultz G; Nair K
J Cancer Res Clin Oncol; 1997; 123(3):161-6. PubMed ID: 9119881
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors for gestational trophoblastic tumors following complete hydatidiform mole].
Grzybowski W; Płoszyński A; Mielnik J; Adamcio-Deptulska M; Preis K; Wojciechowska D
Ginekol Pol; 2002 Nov; 73(11):1003-10. PubMed ID: 12722390
[TBL] [Abstract][Full Text] [Related]
10. Differential expression patterns of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) -1, -4, -5, and -14 in human placenta and gestational trophoblastic diseases.
Lee SY; Lee HS; Gil M; Kim CJ; Lee YH; Kim KR; Park CS
Arch Pathol Lab Med; 2014 May; 138(5):643-50. PubMed ID: 24786121
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of NF-κBp65 and IκBα in gestational trophoblastic disease and clinical significance].
Ju LL; Liu HN; Cai JT; Xu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1084-7. PubMed ID: 23046941
[TBL] [Abstract][Full Text] [Related]
12. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
13. [Expression of TM4SF9 in human trophoblasts].
Gao TY; Yu YH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1080-2. PubMed ID: 18583270
[TBL] [Abstract][Full Text] [Related]
14. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
[TBL] [Abstract][Full Text] [Related]
15. [The expression of EMT associated protein CK-18 and vimentin in gestational trophoblastic disease ].
Cai Y; Xue Y; An RF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):960-3, 1014. PubMed ID: 25571724
[TBL] [Abstract][Full Text] [Related]
16. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
17. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
18. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 20 as a biomarker of gestational trophoblastic disease: diagnostic and prognostic significance.
Stackievicz R; Drucker L; Zemer R; Klein A; Markovitch O; Yarkoni S
Gynecol Oncol; 2002 Oct; 87(1):34-8. PubMed ID: 12468339
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the Parkinson disease protein DJ-1 and its regulator PTEN in gestational trophoblastic disease.
Zhang HJ; Siu MK; Jiang LL; Mak VC; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2010 Sep; 29(5):468-75. PubMed ID: 20736773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
